NKGen Biotech, Inc. (NKGN): insider trading, Congress trades & who owns it

Insider signal
50/100
Neutral · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
—
13F filings
Congress trades
None
none in 2 years

There have been no open-market insider trades at NKGen Biotech, Inc. in the last 12 months.

No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.

Want the full picture on NKGN? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full NKGN report — free account

Latest insider trades in NKGN

FiledInsiderRoleTypeSharesPriceValueSource
Jun 2, 2025Cherng Andrew Jin-Chan10% OwnerBuy19,669,552$0.13$2.6MSEC
May 7, 2025Song Paul Y.CEOBuy20,849,725$0.13$2.7MSEC
Dec 7, 2023Song Paul Y.CEOBuy76$3.29$250SEC
Dec 7, 2023Song Paul Y.CEOBuy75$3.32$250SEC
Dec 5, 2023Song Paul Y.CEOBuy105$3.33$350SEC
Dec 5, 2023Song Paul Y.CEOBuy163$3.07$500SEC
Dec 5, 2023Graf James ACFOBuy450$3.19$1KSEC
Dec 5, 2023Graf James ACFOBuy220$3.35$737SEC
Nov 28, 2023Song Paul Y.CEOBuy140$2.85$400SEC
Nov 28, 2023Song Paul Y.CEOBuy103$2.91$300SEC
Nov 22, 2023Graf Acquisition Partners IV LLCCFOBuy10$2.94$29SEC
Nov 22, 2023Graf Acquisition Partners IV LLCCFOBuy13$2.92$38SEC
Nov 22, 2023Song Paul Y.CEOBuy53$2.85$150SEC
Nov 22, 2023Song Paul Y.CEOBuy100$2.80$280SEC

Questions about NKGN

Are insiders buying or selling NKGN stock?

There were no open-market insider trades in NKGN in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

Has any member of Congress traded NKGN?

No congressional trades in NKGN were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).